Records are not currently really designed for patient use (exception is renal patientview) and are not integrated with private sector (the nhs should not meet costs either but often does in the end). Trial comms common and filed in Gp notes (usually summary at start/end)

ViiV Healthcare has ranked #1 for the 13th consecutive year in the PatientView Corporate Reputation of Pharma survey. Given the company’s consistently high rankings, we recently spoke with Ama Appiah, Patient Affairs Lead, at ViiV Healthcare. Read the Q&A: tinyurl.com/yskv2mxf

🧑‍🔬 100% of lay summaries were validated by patients. Servier was ranked 1⃣ worldwide in oncology patient centricity (PatientView survey, an independent global survey of patient organizations assessing pharmaceutical companies’ patient engagement). Learn more 👉 f.mtr.cool/sifgfvaiuh #WeAreServier #PatientCentric #AnnualReport #MovedByYou

This Thursday, PatientView will release The Corporate Reputation of Pharma 2025/26 – Global Edition. Results will reveal how the pharma industry and pharma companies have performed in 2025, drawing on 2,403 patient group perspectives. Contact alexwyke@patient-view.com for details

Los pacientes en el centro de todo lo que hacemos ❤️‍🩹  Nos situamos en el Top 10 del ranking @PatientView como una de las empresas farmacéuticas con mejor reputación @Servier ✨ #WeAreServier #MovedByYou  servier.es/estudio-patientvi…

This is a final call to patient groups! Today is the last day to participate in the PatientView Corporate Reputation of Pharma 2025 Survey. Help us shape the future of healthcare and participate! Access the survey in your preferred language: patient-view.com/corporate-r…

There's just 1 day left to complete the PatientView Corporate Reputation of Pharma 2025 Survey. By filling out the short survey, you can help strengthen the patient voice & shape the future of healthcare. Complete the survey in your preferred language: tinyurl.com/5x5pj2pa

We're calling on patient groups - the clock is ticking! There are only two days left to complete the PatientView Corporate Reputation of Pharma 2025 Survey. This is your chance to be part of the movement, complete the survey here: patient-view.com/corporate-r…

This is a call to patient groups, there are just 3 days left to complete the PatientView Corporate Reputation of Pharma 2025 Survey! Your insights are powerful, and they deserve to be heard. Complete the short survey here: patient-view.com/corporate-r…

Renal patients have used similar apps for years. Brilliant for chronic illness where patients understand results that are normal for them but not others. Results came in on PatientView much faster than My Care. Not sure how many would prefer results delayed re: new illness only.

Patient groups, the 1-week countdown has officially begun! You have just 7 days left to complete the PatientView Corporate Reputation of Pharma 2025 survey. Make sure you take part before it’s too late! Here is the link to the survey: patient-view.com/corporate-r…

PatientView sends warm wishes to those celebrating the #LanternFestival. It's now the Year of the Fire Horse, and we encourage patient groups to drive positive change by participating in the Corporate Reputation of Pharma survey before 16th March: patient-view.com/corporate-r…

Patient groups, you have until 16th March to complete the PatientView Corporate Reputation of Pharma Survey! How long does it take? Just a few minutes! Why your voice matters: Your lived experience is essential to driving change. Complete the survey today: tinyurl.com/5x5pj2pa

Thank you to the 1600 patient groups that have already completed the PatientView Corporate Reputation of Pharma 2025 survey. Don't miss your chance to be heard, access the survey here in your preferred language: patient-view.com/corporate-r…

#ZOPS je tudi letos sodeloval v raziskavi Corporate Reputation of Pharma from the Patient Perspective: zveza-pacientov.si/novice/pa… @PatientView #partnerstvo @MinZdravje

How is your pharma company perceived by patient groups & how does this compare to other companies? Every year, patient groups worldwide share their insights in the PatientView Corporate Reputation of Pharma survey. Access the survey here in 23 languages: tinyurl.com/mr2ub5sf

今回、英国PatientViewの国内パートナーとして、患者団体の皆様が製薬企業との日々の活動の中で感じている気づきや課題をお伺いする国際的なアンケートを進めています。このアンケートは、患者団体の声を未来の医療づくりに生かすための大切な取り組みです。詳しくはブログへameblo.jp/patientricitymp/en…

This #WorldCancerDay, we thank the patient groups supporting cancer patients & loved ones. The PatientView Corporate Reputation of Pharma survey gives patients a vital voice. Now open - we're urgently calling on cancer groups worldwide to take part: patient-view.com/corporate-r…

¡Estamos de celebración! Nos situamos entre las 10 primeras compañías en reputación farmacéutica según PatientView 🏆 Un reflejo de nuestro compromiso con los pacientes y con las asociaciones que los representan. @Servier #WeAreServier #MovedByYou

The 2024–2025 FY was marked by major advances in oncology, reinforcing our commitment to innovation for patients with rare cancers. 🎗️ This year: global marketing authorizations, 3 key partnerships, 8 medicines available, and a robust pipeline of 34 oncology projects. 🚀 We’re proud to be ranked #1 by oncology patient groups in the PatientView survey. 👉 Read the press release: f.mtr.cool/lubgbcwgtn #ServierResults #innovation #RnD #WeAreServier #MovedByYou